Research

rs1049255 — CYBA CYBA 3'UTR A640G

3'UTR variant in the NADPH oxidase p22-phox subunit affecting superoxide generation and vascular oxidative stress

Moderate Risk Factor Share

Details

Gene
CYBA
Chromosome
16
Risk allele
C
Clinical
Risk Factor
Evidence
Moderate

Population Frequency

CC
25%
CT
50%
TT
25%

See your personal result for CYBA

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

CYBA A640G — The Oxidative Stress Rheostat in Your Blood Vessels

Your blood vessels rely on a delicate balance between two opposing forces: nitric oxide (NO), which relaxes and protects the endothelium, and superoxide, a reactive oxygen species that consumes NO and damages vessel walls. The rs1049255 variant in the CYBA gene shifts this balance by altering how much superoxide your endothelial cells generate — and the consequences reach from blood pressure regulation all the way to ischemic stroke risk.

The Mechanism

CYBA encodes p22-phox11 p22-phox
cytochrome b-245 alpha chain, the stabilizing and activating subunit of the NADPH oxidase complex
. NADPH oxidase (NOX2) is the primary enzymatic source of superoxide in vascular tissue — it transfers electrons from NADPH to molecular oxygen, generating O₂⁻ (superoxide radical). p22-phox is essential for stabilizing the catalytic gp91-phox subunit and for docking the regulatory cytosolic components that activate the complex.

The rs1049255 variant sits in the 3' untranslated region (3'UTR) of CYBA at genomic position chr16:88,643,329 (GRCh38). This region does not alter the p22-phox protein sequence, but 3'UTR sequences regulate mRNA stability and translation efficiency through microRNA binding sites and RNA-binding proteins. rs1049255 falls within a three-variant haplotype (rs4673-rs1049254-rs1049255) that, when all three variant alleles are present, is associated with decreased reactive oxygen species generation22 associated with decreased reactive oxygen species generation
Gavino et al. 2017, PMID 29132304 confirming haplotype is benign for CGD but alters ROS output
. The rs1049255 T allele (plus-strand notation; c.*24A on the coding strand) reduces NADPH oxidase efficiency, generating less vascular superoxide.

Excess superoxide has two damaging effects in blood vessels: first, it reacts with nitric oxide at near-diffusion-limited rates to form peroxynitrite, destroying the NO that normally keeps endothelial cells relaxed and anti-inflammatory. Second, it promotes eNOS uncoupling33 eNOS uncoupling
when eNOS loses its BH4 cofactor due to oxidative degradation, it switches from making NO to making more superoxide — a vicious cycle
. The CC genotype (reference homozygote) drives higher NADPH oxidase activity, more superoxide, more NO depletion, and a shifted endothelial phenotype toward vasoconstriction and platelet activation.

The Evidence

The vascular consequences of rs1049255 genotype have been demonstrated across multiple cardiovascular phenotypes.

A case-control study of 558 ischemic stroke patients and 557 healthy controls in Chinese Han population44 558 ischemic stroke patients and 557 healthy controls in Chinese Han population
Yan JT et al., Acta Pharmacol Sin, 2011
found that carrying the CC or CT genotype of rs1049255 combined with the GCH1 rs841 GA+AA genotype was associated with ischemic stroke (OR=1.73, 95% CI 1.27–2.35, p<0.0001). The combined analysis reveals how CYBA-driven superoxide excess interacts with reduced GCH1 expression to compound NO deficiency.

A Russian case-control study of 445 stroke patients and 442 controls55 445 stroke patients and 442 controls
Bushueva OY et al., Zh Nevrol Psikhiatr, 2015
found the heterozygous CT genotype (one copy of the T allele) directly protective for ischemic stroke (OR=0.75, 95% CI 0.57–0.99, p=0.04), the first study to demonstrate a direct association between rs1049255 genotype and stroke risk independent of other pathway SNPs.

A large Russian study of 436 ischemic heart disease patients and 370 controls66 436 ischemic heart disease patients and 370 controls
Bushueva OY, Kardiologiia, 2020
confirmed the T allele's cardioprotective effect: OR=0.79 (95% CI 0.65–0.96, p=0.02) in the full cohort, with stronger protection in men (OR=0.72).

Mechanistically, the GaoYou arterial elasticity study in 2,178 Chinese participants77 2,178 Chinese participants
Zhu et al., J Hum Hypertens, 2012
demonstrated that CC homozygotes had significantly lower small artery elasticity (5.31 vs. 5.52 ml/mmHg×100, p=0.01) — a measure of endothelial function — compared to T allele carriers. Physical inactivity amplified this effect: among sedentary CC carriers, small artery elasticity dropped to 4.69 versus 5.26 in sedentary T carriers (p=0.008), suggesting that physical activity can partially compensate for the genotype's oxidative burden.

Practical Actions

CC homozygotes carry higher vascular superoxide load, which can be partially offset through interventions that boost NO production or reduce oxidative stress through mechanisms independent of NADPH oxidase. Nitrate-rich foods (beetroot, spinach, rocket) bypass NOS entirely by supplying dietary nitrate that converts to NO via the enterosalivary nitrate- nitrite-NO pathway. Flavonoid-rich foods (particularly cocoa and green tea) directly inhibit NADPH oxidase assembly. High-intensity physical activity upregulates endothelial shear stress responses, increasing eNOS expression and partially counteracting superoxide-driven NO depletion. Monitoring blood pressure and endothelial function markers provides early warning of progressing vascular dysfunction.

Interactions

rs1049255 has documented genetic interactions in the nitric oxide pathway. The combined effect with rs841 (GCH1 intronic variant) on ischemic stroke risk (OR=1.73) is larger than either SNP's independent effect, suggesting a multiplicative interaction88 multiplicative interaction
when CYBA overproduces superoxide AND GCH1 expression is reduced, BH4 is both depleted faster by ROS and synthesized at a lower rate — doubly uncoupling eNOS
.

Within the CYBA gene itself, rs1049255 is in linkage disequilibrium with rs4673 (the C242T missense variant, p.Tyr72His) and rs1049254 — these three variants form a functional haplotype associated with altered ROS output. Genotyping rs4673 alongside rs1049255 provides complementary information about the overall CYBA-driven oxidative burden.

Genotype Interpretations

What each possible genotype means for this variant:

TT “Low Oxidative Stress Variant” Beneficial

Reduced vascular superoxide generation — favorable NO bioavailability

You carry two copies of the T allele at rs1049255. This genotype is associated with lower NADPH oxidase activity and reduced vascular superoxide production. The T allele is part of the CYBA haplotype (with rs4673 and rs1049254) linked to decreased reactive oxygen species generation. Studies in Russian and Chinese populations show T allele carriers have lower ischemic stroke risk and better small artery elasticity than CC carriers. Approximately 25% of people globally share this genotype.

CT “Intermediate Oxidative Stress” Intermediate Caution

Moderately elevated vascular superoxide — one protective T allele

You carry one C and one T allele at rs1049255, the most common genotype globally (~50% of people). The T allele partially reduces NADPH oxidase activity compared to CC homozygotes. In the Russian stroke study, this genotype showed OR=0.75 compared to CC, conferring meaningful but incomplete protection. Your vascular oxidative burden is intermediate — higher than TT carriers but substantially lower than CC homozygotes.

CC “High Oxidative Stress Variant” High Risk Warning

Elevated vascular superoxide generation — reduced NO bioavailability

The CC genotype drives higher p22-phox-mediated NADPH oxidase activity, generating more vascular superoxide. This excess O₂⁻ consumes nitric oxide to form peroxynitrite, reducing the NO bioavailability that normally maintains vascular tone, inhibits platelet aggregation, and prevents monocyte adhesion to the endothelial wall. Superoxide also oxidatively degrades tetrahydrobiopterin (BH4), the essential cofactor for eNOS, causing NOS uncoupling — where eNOS itself starts producing superoxide instead of NO, creating a self-amplifying oxidative cycle.

Physical activity substantially modifies this genotype's vascular impact. In the GaoYou cohort, physically active CC carriers maintained near-normal artery elasticity (5.32 vs. 5.26 in T allele carriers, non-significant), whereas sedentary CC carriers showed markedly reduced elasticity versus sedentary T carriers (4.69 vs. 5.26, p=0.008). This suggests the shear-stress-driven eNOS upregulation from regular exercise partially compensates for NADPH oxidase-driven NO depletion.